臍帶血庫市場規模、佔有率和成長分析：按儲存方法、服務類型、組件類型、應用、治療應用、最終用戶、所有權模式和地區分類－2026-2033年產業預測

2024 年全球臍帶血庫市場價值為 258 億美元，預計從 2025 年的 273 億美元成長到 2033 年的 428.5 億美元，預測期（2026-2033 年）的複合年成長率為 5.8%。

全球臍帶血庫市場正經歷顯著成長，這主要得益於對造血幹細胞和再生醫學細胞療法的需求不斷成長。研究進展、公眾意識的提高以及創新夥伴關係的推動，使臍帶血庫從一項小眾服務發展成為一個商業性的市場。臍帶血庫負責臍帶血的採集、處理和長期儲存。臍帶血富含造血幹細胞，可用於治療血液癌症和遺傳性疾病，以及再生醫學的實驗性療法。越來越多的臨床試驗凸顯了臍帶血在治療非血液學惡性腫瘤的潛力。這一發展動能將促使醫院和保險公司支持臍帶血庫，從而增加對基礎設施的投資，提高處理標準，降低價格，最終擴大全球範圍內獲得必要治療的機會。

全球臍帶血庫市場的成長要素

由於患者和醫療專業人員對臍帶血諸多益處的認知不斷提高，全球臍帶血庫市場蓬勃發展。這種認知推動了臍帶血保存的普及，越來越多的父母主動採集並安全儲存臍帶血，以備將來醫療用途。隨著臍帶血治療潛力的日益凸顯，父母和醫療專業人員都將其視為一種切實可行的治療選擇，促使企業加大投資，擴大儲存能力和服務範圍。此外，透過加強教育和資訊獲取，臍帶血庫正在建立信任和信譽，擴大影響力，並建立臨床夥伴關係。所有這些因素共同推動了市場擴張和服務多元化。

全球臍帶血庫市場的限制因素

全球臍帶血庫市場面臨高昂的營運和合規成本帶來的嚴峻挑戰。對專業基礎設施、訓練有素的人員和完善的品管系統的需求進一步增加了營運的複雜性和成本。這種情況阻礙了地域擴張和非技術領域的投資，使得小規模企業進入該行業尤其困難。此外，這些成本帶來的經濟負擔往往會導致消費者支付更高的服務費用，這可能會阻礙他們使用臍帶血庫服務，並最終影響市場滲透率和競爭動態。

全球臍帶血庫市場趨勢

全球臍帶血庫市場正經歷顯著成長，這主要得益於儲存臍帶血在臨床和研究領域應用的持續拓展。臍帶血庫、學術機構和生技公司之間日益密切的合作，正在加速創新轉化研究和新型細胞療法的開發。隨著醫療專業人員探索新的適應症和臨床實驗方案，對高品質、標準化的臍帶血庫服務的需求也隨之激增。這一趨勢正將臍帶血庫確立為個人化和再生醫學領域的策略性資產，並透過推動針對治療和實驗用途的獨特生物銀行策略，提升再生醫學解決方案的整體水準。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球臍帶血庫市場規模：依儲存方式分類

• 私人臍帶血庫
• 公共臍帶血庫
• 混合臍帶血庫

全球臍帶血庫市場規模：依服務類型分類

• 收集和運輸服務
• 處理服務
• 冷凍和儲存服務
• 檢測和篩檢服務
• 器官獲取和移植支持服務

全球臍帶血庫市場規模：依成分類型分類

• 臍帶血
• 臍帶組織
• 胎盤血
• 幹細胞增殖及其衍生產品

全球臍帶血庫市場規模：依應用領域分類

• 血液疾病
• 腫瘤學和癌症治療
• 免疫疾病
• 代謝性疾病
• 遺傳性疾病
• 再生醫學
• 神經病變
• 其他

全球臍帶血庫市場規模：依治療應用分類

• 同種異體移植
• 自體移植
• 研究用途

全球臍帶血庫市場規模：依最終用戶分類

• 醫院及移植中心
• 研究機構和大學
• 生物技術和製藥公司
• 專科診所

全球臍帶血庫市場規模：依所有權模式分類

• 獨立臍帶血庫
• 醫院附屬臍帶血庫
• 多服務生物樣本庫

全球臍帶血庫市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Cordlife Group Limited
• Cryo-Cell International, Inc.
• CBR Systems, Inc.
• Global Cord Blood Corporation
• StemCyte, Inc.
• Americord Registry LLC
• FamiCord Group
• Vita 34 AG
• LifeCell International Pvt. Ltd.
• Cryoviva Biotech Pvt. Ltd.
• Smart Cells International Limited
• AlphaCord LLC
• ViaCord, Inc.
• California Cryobank Stem Cell Services LLC
• China Cord Blood Corporation
• Boyalife Group
• Medipost Co., Ltd.
• Singapore Cord Blood Bank
• Canadian Blood Services
• NMDP BioTherapies

結論與建議

Global Cord Blood Banking Market size was valued at USD 25.8 Billion in 2024 and is poised to grow from USD 27.3 Billion in 2025 to USD 42.85 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The global cord blood banking market is experiencing significant growth driven by the rising demand for hematopoietic and regenerative cell therapies. This expansion has transformed the industry from a niche service to a commercially viable marketplace, influenced by advancements in research, heightened public awareness, and innovative partnerships. Cord blood banks facilitate the collection, processing, and long-term storage of umbilical cord blood, primarily rich in hematopoietic stem cells used for treating blood cancers and genetic disorders, alongside experimental therapies in regenerative medicine. The increasing volume of clinical trials highlights the potential of cord blood units in treating non-hematological malignancies. This momentum will encourage hospitals and insurers to support cord blood banking, leading to enhanced infrastructure investment, better processing standards, and more affordable prices, ultimately expanding access to essential treatments globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cord Blood Banking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cord Blood Banking Market Segments Analysis

Global cord blood banking market is segmented by storage type, service type, component type, application, therapeutic use, end user, ownership model and region. Based on storage type, the market is segmented into private cord blood banking, public cord blood banking and hybrid cord blood banking. Based on service type, the market is segmented into collection & transportation services, processing services, cryopreservation & storage services, testing & screening services and retrieval & transplantation support services. Based on component type, the market is segmented into cord blood, cord tissue, placental blood and stem cell expansion & derived products. Based on application, the market is segmented into hematological disorders, oncology & cancer treatment, immune disorders, metabolic disorders, genetic disorders, regenerative medicine, neurological disorders and others. Based on therapeutic use, the market is segmented into allogeneic transplantation, autologous transplantation and research use. Based on end user, the market is segmented into hospitals & transplant centers, research institutes & universities, biotechnology & pharmaceutical companies and specialty clinics. Based on ownership model, the market is segmented into standalone cord blood banks, hospital-integrated cord blood banks and multi-service biobanks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cord Blood Banking Market

The global market for cord blood banking is thriving due to heightened awareness among patients and healthcare providers regarding the numerous benefits of cord blood. This understanding has fostered greater acceptance of cord blood storage, prompting more parents to proactively collect and securely store it for potential future medical uses. As the therapeutic potential of cord blood gains recognition, both parents and healthcare professionals are increasingly viewing it as a viable treatment option, leading to an investment in enhanced storage capabilities and service offerings. Additionally, through improved education and access to information, banks have built trust and credibility, allowing them to broaden their reach and forge clinical partnerships that collectively drive market expansion and service diversification.

Restraints in the Global Cord Blood Banking Market

The growth of the global cord blood banking market faces significant challenges due to high operating and compliance costs. Establishing a specialized infrastructure, along with the need for trained personnel and robust quality management systems, adds layers of operational complexity and expense. This situation discourages investment in geographical expansion and non-technological advancements, making it particularly difficult for smaller providers to enter this sector. Furthermore, the financial burden created by these costs often translates into higher service fees for consumers, which can dissuade them from utilizing these services, ultimately affecting market penetration and competitive dynamics.

Market Trends of the Global Cord Blood Banking Market

The Global Cord Blood Banking market is experiencing significant growth driven by the expanding clinical and research applications for stored cord blood units. Increased collaboration among cord blood banks, academic institutions, and biotechnology firms is facilitating innovative translational research and the development of novel cell-based therapies. As healthcare professionals explore new indications and investigational protocols, the demand for high-quality, standardized banking services is surging. This trend positions cord blood banks as strategic assets in personalized and regenerative medicine, promoting unique biobanking strategies tailored for therapeutic and experimental use, thereby enhancing the overall landscape of regenerative healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Cord Blood Banking Market Size by Storage Type & CAGR (2026-2033)

• Market Overview
• Private Cord Blood Banking
• Public Cord Blood Banking
• Hybrid Cord Blood Banking

Global Cord Blood Banking Market Size by Service Type & CAGR (2026-2033)

• Market Overview
• Collection & Transportation Services
• Processing Services
• Cryopreservation & Storage Services
• Testing & Screening Services
• Retrieval & Transplantation Support Services

Global Cord Blood Banking Market Size by Component Type & CAGR (2026-2033)

• Market Overview
• Cord Blood
• Cord Tissue
• Placental Blood
• Stem Cell Expansion & Derived Products

Global Cord Blood Banking Market Size by Application & CAGR (2026-2033)

• Market Overview
• Hematological Disorders
• Oncology & Cancer Treatment
• Immune Disorders
• Metabolic Disorders
• Genetic Disorders
• Regenerative Medicine
• Neurological Disorders
• Others

Global Cord Blood Banking Market Size by Therapeutic Use & CAGR (2026-2033)

• Market Overview
• Allogeneic Transplantation
• Autologous Transplantation
• Research Use

Global Cord Blood Banking Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Transplant Centers
• Research Institutes & Universities
• Biotechnology & Pharmaceutical Companies
• Specialty Clinics

Global Cord Blood Banking Market Size by Ownership Model & CAGR (2026-2033)

• Market Overview
• Standalone Cord Blood Banks
• Hospital-Integrated Cord Blood Banks
• Multi-Service Biobanks

Global Cord Blood Banking Market Size & CAGR (2026-2033)

• North America (Storage Type, Service Type, Component Type, Application, Therapeutic Use, End User, Ownership Model)
  • US
  • Canada
• Europe (Storage Type, Service Type, Component Type, Application, Therapeutic Use, End User, Ownership Model)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Storage Type, Service Type, Component Type, Application, Therapeutic Use, End User, Ownership Model)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Storage Type, Service Type, Component Type, Application, Therapeutic Use, End User, Ownership Model)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Storage Type, Service Type, Component Type, Application, Therapeutic Use, End User, Ownership Model)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Cordlife Group Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryo-Cell International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CBR Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Cord Blood Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCyte, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Americord Registry LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FamiCord Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vita 34 AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeCell International Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryoviva Biotech Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smart Cells International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AlphaCord LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViaCord, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• California Cryobank Stem Cell Services LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Cord Blood Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boyalife Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medipost Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Singapore Cord Blood Bank
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canadian Blood Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NMDP BioTherapies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations